查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球診斷成像市場 - 2023-2030 年
市場調查報告書
商品編碼
1319150

全球診斷成像市場 - 2023-2030 年

Global Diagnostic Imaging Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球診斷成像市場規模在2022 年達到274 億美元，預計到2030 年將達到416 億美元，預測期內（2023-2030 年）的年複合成長率為5.5%。慢性病和病理疾病患者人數的不斷增加提高了對先進醫學成像程序的需求。

對能及早發現病情的診斷設備的需求不斷增加，推動了先進醫療成像設備市場的發展。隨著技術的進步，圖像檢查後所需的報告時間也大大縮短。隨著技術的升級，成像設備的精確度和準確性也得到了提高。

市場動態

越來越多的產品獲批推動了診斷成像市場的成長

預計在預測期內，不斷成長的市場發展將推動全球醫學成像市場的成長。例如，2022 年4 月，Wipro GE Healthcare 推出了新一代Revolution Aspire CT 掃描儀。 Revolution Aspire 是一種先進的成像解決方案，在印度進行端到端開發和製造。

此外，在2023 年2 月舉行的第75 屆印度放射和成像協會（IRIA）全國大會上，醫療成像和資訊系統領域的前沿企業富士膠片印度公司擴大了其產品和解決方案組合。新產品包括超聲系統Arietta 850 DeepInsight 和Arietta 650 DeepInsight 以及新型核磁共振成像儀APERTO Lucent Non-DICOM 列印機APEOS。此外，該公司還推出了服務與支持行動應用程式"FUJIFILM Connect"。

研究經費的增加有望為全球診斷成像市場帶來成長機會

不斷增加的研究經費有望在未來幾年為全球診斷成像市場帶來發展機會。例如，R&E 基金會的任務是通過設計研究人員和幫助終身的獨創性調查和教育來資助放射學的未來。自1984 年成立以來，該基金會已發放了1,600 多筆贈款。這為放射學研究和加強患者護理提供了7000 萬美元的資金。

預計在預測期內，熟練人員和高效培訓計劃的短缺將阻礙全球診斷成像市場的發展

訓練有素的人員短缺是診斷成像行業面臨的一大挑戰。診斷成像是一個高度專業化的領域，需要專門的培訓和專業知識，而技術熟練的人才日益短缺。

技術人才短缺的主要原因之一是缺乏對診斷成像教育和培訓計劃的投資。許多大專院校沒有開設影像診斷專業課程，而且影像診斷培訓課程數量有限。

COVID-19 影響分析

COVID-19 在全球多個國家的流行和封鎖影響了各行各業公司的財務健康。因此，在COVID-19 公共衛生緊急事件期間，美國食品和藥物管理局(FDA) 發布了指導方針，其中包括幫助申辦者和研究人員的一般注意事項，以確保試驗參與者的安全、遵守良好臨床實踐(GCP)，並將試驗完整性的風險降至最低。

俄烏戰爭影響分析

俄烏衝突被認為對全球診斷成像市場的影響不大，因為該地區缺乏主要的市場參與者。烏克蘭診所雖然繼續忍受俄羅斯軍隊的入侵，但迫於不斷增加的死亡人數和有限的醫療援助。所有類型的醫療援助都出現短缺。同樣，基礎材料進出口的重要性預計將在預測期內對全球診斷成像市場的成長產生輕微影響。

目 錄

第1 章：研究方法與範圍

  • 研究方法
  • 報告的研究目標和範圍

第2章：定義和概述

第3 章：執行摘要

  • 按類型分類
  • 按應用分類
  • 按最終用戶分類
  • 按地區分類

第四章：動態

  • 影響因素
    • 促進因素
      • 市場日益發展
      • 慢性病發病率成長
    • 制約因素
      • 成本高昂
    • 機會
      • 研究經費不斷增加
    • 影響分析

第5 章：行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情況
    • COVID-19 期間的情景
    • COVID-19 後的情況
  • COVID-19 期間的定價動態
  • 供需關係
  • 大流行期間與市場相關的政府計劃
  • 製造商的戰略計劃
  • 結論

第7 章：按類型分類

  • X 射線
    • 模擬成像
    • 數位成像
  • 磁共振成像
    • 低場磁共振成像掃描儀
    • 高場磁共振成像掃描儀
    • 中場磁共振成像掃描儀
  • 核醫學
    • 掃描
    • 正電子發射電腦斷層顯像
    • SPECT 成像
  • SPECT 成像
  • 超音波
    • 二維超音波
    • 3D/四維超聲
    • 多普勒成像
  • 斷層掃描
    • 高階CT 掃描儀
    • 中端切片CT 掃描儀
    • 低階切片CT 掃描儀
  • 觸覺成像
  • 功能性近紅外光譜儀

第8 章：按應用分類

  • 骨科
  • 神經科
  • 腫瘤學
  • 心臟病學
  • 其他應用

第9 章：按最終用戶分類

  • 醫院
  • 診斷成像中心
  • 其他

第10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
      • 亞太其他地區
  • 中東和非洲
    • 特定地區的主要動態

第11 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併與收購分析

第十二章：公司簡介

  • GE Healthcare
    • 公司概況
    • 產品組合和說明
    • 財務概況
    • 主要發展
  • Siemens Healthcare
  • Carestream Health Inc.
  • Hitachi Medical Corporation
  • Canon Toshiba Medical Systems Corporation
  • Hologic Corporation
  • Philips Healthcare
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Mindray

第13 章：附錄

簡介目錄
Product Code: MI390

Market Overview

The Global Diagnostic Imaging Market reached US$ 27.4 billion in 2022 and is expected to reach US$ 41.6 billion by 2030, exhibiting a CAGR of 5.5% during the forecast period (2023-2030). The rising number of people with chronic diseases and pathological diseases has raised the need for avant-garde medical imaging procedures.

The rising need for diagnostic devices that can detect conditions earlier has increased the market for progressive medical imaging devices. With the improvement in technology, the reporting period which is needed after the image has been reviewed has also decreased extensively. The precision and accuracy of imaging devices have even improved with the upgrade in technology.

Market Dynamics

Increasing Product Approvals Drive the Growth of the Diagnostic Imaging Market

The increasing market developments are expected to boost the global medical imaging market growth in the forecast period. For instance, in April 2022, Wipro GE Healthcare introduced the next-generation Revolution Aspire CT scanner. Revolution Aspire is an advanced imaging solution developed and fabricated end-to-end in India.

Moreover, in February 2023, FUJIFILM India, a frontier in healthcare imaging and information systems, expanded its product and solutions portfolio at the 75th National Conference of the Indian Radiological and Imaging Association (IRIA). The new range possesses ultrasound system Arietta 850 DeepInsight and Arietta 650 DeepInsight along with the new MRI machine APERTO Lucent Non-DICOM printer APEOS. Further, the corporation even presented "FUJIFILM Connect" a service & support mobile application.

The Increase in Research Funding is Expected to Present the Global Diagnostic Imaging Market with Growth Opportunities

The increasing research funding is expected to present the global diagnostic imaging market with prospective growth opportunities in the upcoming years. For instance, the assignment of the R&E Foundation is to fund the future of radiology by designing researchers and helping lifelong ingenious investigation and education. Since the Foundation's beginning in 1984, it has granted more than 1,600 grants. That's $70 million in funding for radiology investigation and enhancing patient care.

The Shortage of Skilled Personnel and Efficient Training Programs is Estimated to Hamper the Global Diagnostic Imaging Market During the Forecast Period

The shortage of trained personnel is a considerable challenge facing the diagnostic imaging industry. Diagnostic imaging is a highly specialized field requiring specialized training and expertise, and there is a growing shortage of skilled personnel.

One of the primary reasons for the shortage of skilled personnel is the lack of investment in education and training programs for diagnostic imaging. Many universities and colleges do not offer specialized programs in diagnostic imaging, and there is a limited number of training programs available for diagnostic imaging.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is thought to hold a moderate influence on the global diagnostic imaging market, as there is a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all types of healthcare assistance. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global diagnostic imaging market growth in the forecast period.

Segment Analysis

The global diagnostic imaging market is segmented based on product type, disease type, end-user, and region.

The Tomography Type of Diagnostic Imaging is Estimated to Dominate the Global Diagnostic Imaging Market

The tomography type of diagnostic imaging is expected to hold around 37.8% of the global market share owing to the increasing product introductions into the market. For instance, in May 2023, Royal Philips, a multinational leader in health technology, launched the Philips CT 3500, a new high-throughput CT system targeting the requirements of everyday radiology and high-volume screening schedules.

Powered by AI, the Philips CT 3500 includes a range of image-reconstruction and workflow-enhancing characteristics that aid to provide the consistency, rate, and first-time-right image grade ought for assured diagnoses by clinicians and improved recovery on investment in the highly selective, high-volume care environments.

Moreover, in March 2022, at the 74th National Conference, IRIA 2022, Bengaluru, Siemens Healthineers introduced its latest product MAGNETOM Free. Star and NAEOTOM Alpha in MRI and CT pipeline. These product takeoffs supported the corporation broaden its consumer ground by delivering state-of-the-art medical imaging technology.

Geographical Analysis

Europe is Estimated to Hold 28.6% of the Market Share Owing to the Increasing Chronic Diseases Prevalence in this Region

Owing to the increasing cases of chronic diseases in this region, Europe is estimated to dominate the global market holding around 28.6% of the market by 2030. For instnace, according to the European Heart Network AISBL, annually cardiovascular conditions (CVD) causes 3.9 million casualties in Europe and more than 1.8 million deaths in the European Union (EU), CVD makes up for over 45% of all deaths in Europe and 37% of all deaths in the EU.

CVD is the primary reason for death in males in all whereas 12 nations of Europe and is the primary reason for death in females in all but two countries. Death rates from both ischaemic heart disease (IHD) and stroke are typically more increased in Central and Eastern Europe compared to Northern, Southern, and Western Europe.

Competitive Landscape

The major global players in the diagnostic imaging market include: GE Healthcare, Siemens Healthcare, Carestream Health Inc., Hitachi Medical Corporation, Canon Toshiba Medical Systems Corporation, Hologic Corporation, Philips Healthcare, Fujifilm Holdings Corporation, and Shimadzu Corporation, among others.

Why Purchase the Report?

  • To visualize the global diagnostic imaging market segmentation based on type, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of diagnostic imaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available in excel consisting of key products of all the major players.

The global diagnostic imaging market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Market Developments
      • 4.1.1.2. Growing Incidences of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Research Funding
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. X-Ray *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      • 7.2.2.1. Analog Imaging
      • 7.2.2.2. Digital Imaging
  • 7.3. MRI
    • 7.3.1. Low-Field MRI Scanners
    • 7.3.2. High-Field MRI Scanners
    • 7.3.3. Mid-Field MRI Scanners
  • 7.4. Nuclear Medicine
    • 7.4.1. Scintigraphy
    • 7.4.2. PET Imaging
    • 7.4.3. SPECT Imaging
  • 7.5. SPECT Imaging
  • 7.6. Ultrasound
    • 7.6.1. 2D Ultrasound
    • 7.6.2. 3D/4D Ultrasound
    • 7.6.3. Doppler Imaging
  • 7.7. Tomography
    • 7.7.1. High-End Slice CT Scanners
    • 7.7.2. Mid-End Slice CT Scanners
    • 7.7.3. Low-End Slice CT Scanners
  • 7.8. Tactile Imaging
  • 7.9. Functional near Infrared Spectroscopy

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Orthopedic *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Neurology
  • 8.4. Oncology
  • 8.5. Cardiology
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostics Imaging Centers
  • 9.4. Other

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Siemens Healthcare
  • 12.3. Carestream Health Inc.
  • 12.4. Hitachi Medical Corporation
  • 12.5. Canon Toshiba Medical Systems Corporation
  • 12.6. Hologic Corporation
  • 12.7. Philips Healthcare
  • 12.8. Fujifilm Holdings Corporation
  • 12.9. Shimadzu Corporation
  • 12.10. Mindray

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us